These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1587040)

  • 1. Differential diagnosis of idiopathic fibrosis from malignant lymphadenopathy with PET and F-18 fluorodeoxyglucose.
    Kubota K; Yamada K; Yoshioka S; Yamada S; Ito M; Ido T
    Clin Nucl Med; 1992 May; 17(5):361-3. PubMed ID: 1587040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
    Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
    J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
    Lewis PJ; Salama A
    J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
    Rosenfeld SS; Hoffman JM; Coleman RE; Glantz MJ; Hanson MW; Schold SC
    J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
    Bares R; Klever P; Hauptmann S; Hellwig D; Fass J; Cremerius U; Schumpelick V; Mittermayer C; Büll U
    Radiology; 1994 Jul; 192(1):79-86. PubMed ID: 8208970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
    Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy.
    Reinhardt MJ; Müller-Mattheis VG; Gerharz CD; Vosberg HR; Ackermann R; Müller-Gärtner HW
    J Nucl Med; 1997 Jan; 38(1):99-101. PubMed ID: 8998160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal fibrosis: use of CT in distinguishing among possible causes.
    Degesys GE; Dunnick NR; Silverman PM; Cohan RH; Illescas FF; Castagno A
    AJR Am J Roentgenol; 1986 Jan; 146(1):57-60. PubMed ID: 3484410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of
    Wang Y; Guan Z; Gao D; Luo G; Li K; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhang J; Zhu J; Huang F
    Semin Arthritis Rheum; 2018 Feb; 47(4):593-600. PubMed ID: 28958769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Boland GW; Goldberg MA; Lee MJ; Mayo-Smith WW; Dixon J; McNicholas MM; Mueller PR
    Radiology; 1995 Jan; 194(1):131-4. PubMed ID: 7997539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal IgG4-related sclerosing disease mimics renal pelvic cancer on (18)F-FDG PET/CT.
    Li B; Hou J; Zhang Y; Hou X; Shi H
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):67-9. PubMed ID: 26324752
    [No Abstract]   [Full Text] [Related]  

  • 14. PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose.
    Tsuyuguchi N; Hakuba A; Okamura T; Ochi H; Suzuki T; Sunada I
    J Comput Assist Tomogr; 1997; 21(4):590-3. PubMed ID: 9216763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Dehdashti F; Siegel BA; Griffeth LK; Fusselman MJ; Trask DD; McGuire AH; McGuire DJ
    Radiology; 1996 Jul; 200(1):243-7. PubMed ID: 8657920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET appearance of pelvic Castleman's disease.
    Murphy SP; Nathan MA; Karwal MW
    J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
    Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study.
    Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Miyake Y; Gunasekera R; Masuda K
    J Comput Assist Tomogr; 1989; 13(5):829-31. PubMed ID: 2789238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.